Thu, 09th Aug 2018 14:50
LONDON (Alliance News) - Proteome Sciences said Thursday that Vulpes Life Sciences Fund purchased 1.4 million shares in the company on Tuesday at 3.50 pence each.
Vulpes now has a 19.6% holding in the company, equivalent to an interest in 57.8 million shares.
Martin Diggle, director of both Vulpes Investment Management and Proteome, now also holds a 19.6% interest in Proteome.
Shares in Proteome were down 2.5% at 3.558 pence each on Thursday.
Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "con...
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...
Proteome (PRM)